ANGIOTECH PHARMACEUTICALS INC Stock-Based Compensation
ANGIOTECH PHARMACEUTICALS INC reported Stock-Based Compensation of $2.82 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-12-31 was $807.00K.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $694.00K, a 78.61% decline year-over-year.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $746.00K.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $573.00K.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2012 was $2.82M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 5 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 8 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2012-12-31 | $807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.50M derived: sum of 2 quarters · filed 2013-03-28 | $2.25M derived: sum of 3 quarters · filed 2013-03-28 | $2.82M 10-K · filed 2013-03-28 | ||
| 2012-09-30 | $694.00K 10-Q · filed 2012-11-14 | $1.44M derived: sum of 2 quarters · filed 2012-11-14 | $2.01M 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | $746.00K 10-Q/A · filed 2012-09-13 | $1.32M 10-Q/A · filed 2012-09-13 | ||||
| 2012-03-31 | $573.00K 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | $9.84M 10-K · filed 2013-03-28 | |||||
| 2011-09-30 | $3.24M 10-Q · filed 2012-11-14 | $3.24M 10-Q · filed 2012-11-14 |